Selenocystine - CAS 2897-21-4

Selenocystine, a broad-spectrum anticancer agent, effectively induces DNA damage, notably DNA double-strand breaks (DSBs), in HepG2 cells, showcasing significant potential as a therapeutic or adjuvant agent in targeting DNA repair mechanisms for cancer treatment [1].

Others, Endogenous Metabolite

Others, Metabolism

2872

C6H12N2O4Se2

334.09

C(C[Se][Se]CC(C(O)=O)N)(C(O)=O)N

-20°C

Ice Packs

Small Compound